Loading…
Characterization of VRC 01, a potent and broadly neutralizing anti‐ HIV m A b, produced in transiently and stably transformed tobacco
Summary The proposed clinical trial in A frica of VRC 01, a potent broadly neutralizing antibody (b NA b) capable of neutralizing 91% of known HIV ‐1 isolates, raises concerns about testing a treatment which will be too expensive to be accessible by the most important target population, the poor in...
Saved in:
Published in: | Plant biotechnology journal 2014-04, Vol.12 (3), p.300-311 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Summary
The proposed clinical trial in
A
frica of
VRC
01, a potent broadly neutralizing antibody (b
NA
b) capable of neutralizing 91% of known
HIV
‐1 isolates, raises concerns about testing a treatment which will be too expensive to be accessible by the most important target population, the poor in under‐developed regions such as sub‐
S
aharan
A
frica. Here, we report the expression of
VRC
01 in plants as an economic alternative to conventional mammalian‐cell‐based production platforms. The heavy and light chain genes of
VRC
01 were cloned onto a single vector, p
TRA
k.2, which was transformed into
N
icotiana benthamiana
or
N
icotiana tabacum
using transient and stable expression production systems respectively.
VRC
01 has been successfully expressed transiently in plants with expression level of approximately 80 mg antibody/kg; stable transgenic lines expressing up to 100 mg antibody/kg were also obtained. Plant‐produced
VRC
01 from both systems showed a largely homogeneous
N
‐glycosylation profile with a single dominant glycoform. The binding kinetics to gp120
IIIB
(approximately 1 n
m
), neutralization of
HIV
‐1
B
a
L
or a panel of 10
VRC
01‐sensitive
HIV
‐1
E
nv pseudoviruses of
VRC
01 produced in transient and stable plants were also consistent with
VRC
01 from
HEK
cells. |
---|---|
ISSN: | 1467-7644 1467-7652 |
DOI: | 10.1111/pbi.12137 |